New practices in computational modeling

Clinical Cancer Research

Volumn 13, Issue 4, 2007, Pages 1074-1075

  Greco, William R ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN;

CANCER RESEARCH; CLINICAL PRACTICE; DRUG DISTRIBUTION; DRUG MECHANISM; EDITORIAL; MEDICAL LITERATURE; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; COMPUTER SIMULATION; DISEASE MODELS, ANIMAL; DOGS; DOXORUBICIN; HUMANS; MODELS, BIOLOGICAL; PHARMACOKINETICS;

EID: 33947200737     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-2811     Document Type: Editorial

References (6)

1. Hu L, Au L-S, Wientjes MG. Computational modeling to predict effect of treatment schedule on drug delivery to prostate in humans. Clin Cancer Res 2007;13:1278-87.
2. Bischoff KB, Dedrick RL. Thiopental pharmacokinetics. J Pharm Sci 1968;57:1346-51.
3. Bischoff KB, Dedrick RL, Zaharko DS. Preliminary model for methotrexate pharmacokinetics. J Pharm Sci 1970;59:149-54.
4. Bischoff KB, Dedrick RL, Zaharko DS, Longstreth JA. Methotrexate pharmacokinetics. J Pharm Sci 1971;60:1128-33.
5. Bischoff KB. Some fundamental considerations of the application of pharmacokinetics to cancer chemotherapy. Cancer Chemother Rep 1975;59:777-93.
6. Davies B, Morris T. Physiological parameters in laboratory animals and humans. Pharm Res 1993;10:1093-5.